drugset / Trial / NCT01002092
A Study of Endostar Combined With Chemotherapy for Treatment of Osteosarcoma
RandomizedParallel-groupOpen-labelTreatment
Summary
Purpose: This study will assess the safety and efficacy of Endostar combined with chemotherapy in osteosarcoma patients.
Timeline
- Start
- 2009-02
- Primary completion
- 2014-12
- Completion
- 2014-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Endostar | Protein / enzyme biologic | 7.5 mg/m2 | — |
| Background | ADM | Unknown | 60 mg/m2 | — |
| Background | CDP | Unknown | 100 mg/m2 | — |
| Background | CDP | Unknown | 120 mg/m2 | — |
| Background | IFO | Unknown | 2 g | — |
| Background | MTX | Unknown | 8 unknown | — |
| Background | THP | Unknown | 60 mg/m2 | — |